BACKGROUND: Epidemiologic data suggest a protective effect of Helicobacter pylori infection against the development of autoimmune disease. Laboratory data illustrate H. pylori's ability to induce immune tolerance and limit inflammatory responses. Numerous observational studies have investigated the association between H. pylori infection and inflammatory bowel disease (IBD). Our aim was to perform a systematic review and meta-analysis of this association. METHODS: Medline, EMBASE, bibliographies, and meeting abstracts were searched by 2 independent reviewers. Of 369 abstracts reviewed, 30 promising articles were reviewed in detail. Twenty-three studies met our inclusion criteria (subject N = 5903). Meta-analysis was performed with the metan command in Stata 10.1. RESULTS: Overall, 27.1% of IBD patients had evidence of infection with H. pylori compared to 40.9% of patients in the control group. The estimated relative risk of H. pylori infection in IBD patients was 0.64 (95% confidence interval [CI]: 0.54-0.75). There was significant heterogeneity in the included studies that could not be accounted for by the method of IBD and H. pylori diagnosis, study location, or study population age. CONCLUSIONS: These results suggest a protective benefit of H. pylori infection against the development of IBD. Heterogeneity among studies and the possibility of publication bias limit the certainty of this finding. Further studies investigating the effect of eradication of H. pylori on the development of IBD are warranted. Because environmental hygiene and intestinal microbiota may be strong confounders, further mechanistic studies in H. pylori mouse models are also necessary to further define the mechanism of this negative association.
BACKGROUND: Epidemiologic data suggest a protective effect of Helicobacter pylori infection against the development of autoimmune disease. Laboratory data illustrate H. pylori's ability to induce immune tolerance and limit inflammatory responses. Numerous observational studies have investigated the association between H. pyloriinfection and inflammatory bowel disease (IBD). Our aim was to perform a systematic review and meta-analysis of this association. METHODS: Medline, EMBASE, bibliographies, and meeting abstracts were searched by 2 independent reviewers. Of 369 abstracts reviewed, 30 promising articles were reviewed in detail. Twenty-three studies met our inclusion criteria (subject N = 5903). Meta-analysis was performed with the metan command in Stata 10.1. RESULTS: Overall, 27.1% of IBD patients had evidence of infection with H. pylori compared to 40.9% of patients in the control group. The estimated relative risk of H. pyloriinfection in IBD patients was 0.64 (95% confidence interval [CI]: 0.54-0.75). There was significant heterogeneity in the included studies that could not be accounted for by the method of IBD and H. pylori diagnosis, study location, or study population age. CONCLUSIONS: These results suggest a protective benefit of H. pyloriinfection against the development of IBD. Heterogeneity among studies and the possibility of publication bias limit the certainty of this finding. Further studies investigating the effect of eradication of H. pylori on the development of IBD are warranted. Because environmental hygiene and intestinal microbiota may be strong confounders, further mechanistic studies in H. pylorimouse models are also necessary to further define the mechanism of this negative association.
Authors: G Oberhuber; A Püspök; C Oesterreicher; G Novacek; C Zauner; M Burghuber; H Vogelsang; R Pötzi; M Stolte; F Wrba Journal: Gastroenterology Date: 1997-03 Impact factor: 22.682
Authors: Hoda M Malaty; Abdalla El-Kasabany; David Y Graham; Charles C Miller; Sidd G Reddy; Sathanur R Srinivasan; Yoshio Yamaoka; Gerald S Berenson Journal: Lancet Date: 2002-03-16 Impact factor: 79.321
Authors: Mark A Feeney; Frank Murphy; Andrew J Clegg; Timothy M Trebble; Nicholas M Sharer; Jonathon A Snook Journal: Eur J Gastroenterol Hepatol Date: 2002-05 Impact factor: 2.566
Authors: P O Väre; B Heikius; J A Silvennoinen; R Karttunen; S E Niemelä; J K Lehtola; T J Karttunen Journal: Scand J Gastroenterol Date: 2001-12 Impact factor: 2.423
Authors: Bodo Linz; François Balloux; Yoshan Moodley; Andrea Manica; Hua Liu; Philippe Roumagnac; Daniel Falush; Christiana Stamer; Franck Prugnolle; Schalk W van der Merwe; Yoshio Yamaoka; David Y Graham; Emilio Perez-Trallero; Torkel Wadstrom; Sebastian Suerbaum; Mark Achtman Journal: Nature Date: 2007-02-07 Impact factor: 49.962
Authors: Mathias Oertli; Manuel Noben; Daniela B Engler; Raphaela P Semper; Sebastian Reuter; Joachim Maxeiner; Markus Gerhard; Christian Taube; Anne Müller Journal: Proc Natl Acad Sci U S A Date: 2013-02-04 Impact factor: 11.205
Authors: A Velasco-Guardado; A Mora-Soler; L López-Corral; O López-Godino; L Vázquez-López; O Blanco-Muñez; E Pérez-López; A Rodríguez-Pérez; D Caballero-Barrigón Journal: Bone Marrow Transplant Date: 2016-03-07 Impact factor: 5.483